Perrigo | PRGO - Pasivo Circulante





Pasivo Circulante Cambio Fecha
AbbVie USD 42.1B 1.19B 2026-03
Abbott USD 18.38B 1.88B 2026-03
Bayer EUR 33.46B 875M 2026-03
Bristol-Myers Squibb USD 19.16B 4.26B 2026-03
Coherus Biosciences USD 140.39M 231.91M 2025-12
Corcept Therapeutics USD 149.18M 16.9M 2026-03
Dr.Reddys Laboratories INR 167.47B 9.16B 2026-03
Eli Lilly USD 36.63B 1.41B 2026-03
J&J USD 57.72B 3.59B 2026-03
Merck USD 26.94B 1.38B 2026-03
Nestle CHF 40.69B 6.13B 2025-12
Pacira USD 108.79M 11.8M 2026-03
Perrigo USD 997.6M 15.3M 2026-03
Pfizer USD 34.35B 2.64B 2026-03
Phibro Animal Health USD 281.87M 500K 2026-03
Prestige Brands USD 120.92M 18.63M 2026-03
Reckitt Benckiser GBP 7.94B 901M 2024-12
Sanofi EUR 30.01B 1.66B 2026-03
Supernus Pharmaceuticals USD 373.93M 35.76M 2026-03
Teva Pharmaceutical Industries USD 13.53B 76M 2026-03
Xeris Pharmaceuticals USD 118.59M 9.02M 2026-03
Zoetis USD 2.05B 182M 2026-03